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The epidemiology of human rabies postexposure pro-
phylaxis (PEP) in 4 upstate New York counties was
described from data obtained from 2,216 incidences of
PEP recorded by local health departments from 1995 to
2000. Overall annual incidence for the study period was 27
cases per 100,000 persons. Mean annual PEP incidence
rates were highest in rural counties and during the summer
months. PEP incidence was highest among patients 5–9
and 30–34 years of age. Bites accounted for most PEP
(51%) and were primarily associated with cats and dogs.
Bats accounted for 30% of exposures, more than any other
group of animals; consequently, bats have replaced rac-
coons as the leading rabies exposure source to humans in
this area.
C
ombined with effective human rabies prophylaxis,
canine rabies control programs were responsible for
the steady decline of human rabies in the United States,
from 20–25 annual cases in the 1940s to <3 annual cases
in the 1990s (1–4). Although the current incidence of
human rabies in the United States is negligible compared
to that of other infectious diseases, the number of persons
seeking rabies postexposure prophylaxis (PEP) is high;
18,238 persons received PEPin New York (excluding New
York City) from 1993 to 1998 (5). No proven curative
treatment has been documented for rabies once clinical
disease begins (6). Human rabies can be prevented by fol-
lowing the Advisory Committee on Immunization
Practices (ACIP) recommendations of local wound care
and prompt administration of human rabies immune glob-
ulin (HRIG, 20 IU/kg) on day 0 and vaccine on days 0, 3,
7, 14, and 28 (7). For persons who have been previously
vaccinated, the recommended prophylaxis consists of a
vaccine dose on days 0 and 3.
Studies addressing rabies PEP incidence indicate a ris-
ing trend since the 1970s. Estimates of annual PEP inci-
dence in Georgia increased from 1.94 cases/100,000 in
1970 to an estimated 6.17 cases/100,000 from 1995 to
2001 (1, S.J. Onufrak, Source-specific risks among
patients receiving rabies post-exposure prophylaxis in
Georgia [master’s thesis]. Atlanta: Emory University;
2003). At the national level, incidence was most recently
estimated at 8.69 cases/100,000 in 1980 (8). Increases are
probably attributable to an expanding raccoon rabies epi-
zootic in the mid-Atlantic states and changes in PEP con-
sideration after potential bat exposure (5). We describe
demographic and animal exposure data associated with
PEP in upstate New York several years after the establish-
ment of the raccoon rabies variant and compare them with
1993–1994 data from the same area (9). 
Methods
Monroe and Onondaga Counties encompass the cities
of Rochester and Syracuse and are predominantly urban-
suburban with population densities of 422 and 232 per-
sons/km2, respectively. Cayuga and Wayne Counties are
predominantly rural-suburban, with population densities of
46 and 60 persons/km2, respectively. The 4-county region
in western upstate New York is 7,086 km2, with an estimat-
ed human population of 1,369,407 (10).
We considered all PEP cases recorded on standardized
reports by the 4 local health departments from 1995 to
2000. Data included patient demographics, animal charac-
teristics, and exposure details. The report form was
changed in 1998, with the addition of age, sex, treatment
dates, and more detailed exposure information for bat-
related PEP. Age and sex data were obtained directly from
local health departments for PEP cases before 1998.
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firmed rabid animal that directly or indirectly resulted in
potential human exposure. Direct exposure consisted of a
bite, scratch, or contamination of mucous membrane with
potentially infectious material directly from a suspected
rabid animal. Indirect exposure consisted of contact with
potentially contaminated fomites (e.g., saliva from a pet’s
fur that comes into contact with open wounds or mucous
membranes). Cases that lacked specific information about
route of exposure were classified as unspecified. Cryptic
or unspecified bat exposures consisted of discovering a bat
in a room with a sleeping person, unattended child, men-
tally impaired person, intoxicated person, or someone oth-
erwise unable to rule out contact. Rabies diagnostic results
were obtained on animal cases from the New York State
Department of Health Wadsworth Center Rabies
Laboratory. Population data from the 2000 US census were
used to calculate the incidence of PEP by county, age, and
sex (10). Statistical analyses, including frequencies and
chi-square tests, were performed with the SAS statistical
package version 8.0 (SAS Institute Inc., Cary, NC, USA). 
Results
Atotal of 2,216 PEPcases were reported from the study
area from 1995 to 2000, with 317–469 cases each year.
Annual PEP incidence was 23–34 cases/100,000 during
the 6-year period (average 27/100,000). The mean annual
incidence for the urban counties of Monroe and Onondaga
(319 residents/km2) was 23 cases/100,000 compared to 56
cases/100,000 in the rural counties of Cayuga and Wayne
(52 residents/km2). No failures of PEP were recorded.
PEP cases tended to increase in the late spring/early
summer; the highest number of PEP cases was seen in
August/September in 1996 and 1997 and in July/August
from 1998 to 2000 (Figure 1). Of 2,109 (95%) PEP cases
for which sex data were available, 51% were male. The
median age of PEP recipients was 27 years for men and 29
years for women. The mean annual incidence of PEP for
men was 26 cases/100,000 and for women 24 cases/
100,000. PEP incidence rates were highest in persons 5–9
years of age, followed by those 30–34 years of age (Figure
2). No significant differences among sex or age distribu-
tions and PEP were seen.
Wild animal exposures accounted for 1,081 PEP cases
(49%), domestic animals accounted for 1,057 cases (48%),
and species of exposure animal was not identified for 78
cases (3%) (Table 1). Bats accounted for 663 (61%) PEP
cases related to wildlife exposures, while other sources of
wildlife-related PEP included raccoons (250 cases), foxes
(85 cases), skunks (46 cases), woodchucks (12 cases),
opossums (6 cases), deer (5 cases), beavers, coyotes, and
squirrels (3 cases each), and other wild species (5 cases).
PEP from bat exposure was significantly associated with
an urban setting (p<0.001). Among domestic animal expo-
sures that resulted in PEP, 523 were attributed to cats, 498
to dogs, 19 to cattle, 11 to horses, 4 to ferrets, and 1 each
to a pet rabbit and monkey.
Animals were not available for observation or testing
for 66% of rabies PEP cases that resulted from exposure to
cats and 89% that resulted from exposures to dogs. Of the
dog-associated PEP, significantly (p<0.001) more of them
(93%) occurred in urban counties compared to rural coun-
ties (Table 2). During the study period, only 16 (3%) dog-
associated PEP cases involved dogs that were tested for
rabies, and none were confirmed rabid. Among cats, 132
(25%) cat-associated PEP cases involved cats that were
tested for rabies; of these, 110 PEP cases (83%) involved
exposure to a confirmed rabid cat. 
Atotal of 1,128 (51%) PEPcases were attributed to ani-
mal bite; 670 (30%) persons reported nonbite exposures,
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Figure 1. Human rabies postexposure prophylaxis (PEP) by month
and species of exposure (domestic vs. wild), 4 upstate New York
counties (Cayuga, Monroe, Onondaga, and Wayne), 1995–2000.
Figure 2. Human rabies postexposure prophylaxis (PEP) inci-
dence by sex and age group, 4 upstate New York counties
(Cayuga, Monroe, Onondaga, and Wayne), 1995–2000.and 418 (19%) reported exposure as unknown or unspeci-
fied (Table 1). Among nonbite-associated PEP recipients,
69% reported direct animal contact. Of the 1,106 bite-
related PEP recipients that reported the species, 78%
involved domestic animals. In 62% of potential exposures
to bats, an exposure route was not described. 
Exposure of only 1 person to a suspected rabid animal
precipitated 1,336 (60%) PEP cases (Table 3). Exposure of
a single person was more likely to be associated with a bite
(p<0.001). Wild animal species accounted for 72% of
group exposure PEP. The largest group occurred in June
1999, when 29 persons received PEP after exposure to a
rabid cat.
Laboratory diagnosis of rabies was sought in 249 ani-
mals associated with 515 PEP cases (23%). Contact with a
wild animal accounted for 348 cases (68%) where labora-
tory diagnosis was sought. Raccoons accounted for 176
(57%) of 309 PEP cases attributed to confirmed rabid
wildlife. Nonbite exposures accounted for 366 (73%) of
501 PEP cases in which a laboratory diagnosis of rabies
was obtained. Laboratory diagnosis of rabies in the expos-
ing animal was significantly associated with nonbite expo-
sure (p<0.001).
From 1998 to 2000, the time of PEP initiation in rela-
tion to exposure was available for 1,219 (98%) of 1,248
cases. The period between exposure and treatment varied
from 0 to 115 days with a median of 3 days. Among per-
sons with bite exposure, 199 (38%) of 528 began PEP the
same day as exposure, while 14% of persons who reported
a nonbite exposure received treatment the same day as
exposure (p<0.001). Medians of 1 day for wild animal
exposures and 2 days for domestic animal exposures were
associated with bite exposures and 3 and 6 days, respec-
tively, for nonbite exposures.
Of 1,248 PEP cases reported from 1998 to 2000,
administration of PEP biologics was recorded as complete
and appropriate (e.g., HRIG was given if indicated and the
person completed all 5 vaccinations) in 1,035 (83%) cases.
A total of 62 persons (5%) had received prior vaccination;
47 (76%) completed the appropriate course of treatment.
Among rabies vaccination–naive persons, 984 (85%) of
1,157 completed the appropriate course of treatment.
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Rabies Postexposure Prophylaxis, New YorkInformation regarding treatment scheduling was not avail-
able for 29 (2%) PEP cases.
Information on vaccine scheduling was available for
724 (58%) of the 1998–2000 PEP cases. Administration
schedules were correct for 605 (84%) persons. Six persons
(1%) did not receive HRIG when it was indicated, and 9
(1%) previously vaccinated persons received HRIG,
although it was not indicated. One person received 6 total
vaccine doses. Adverse events were listed as either present
or absent with no scale as to severity. In all, 63 persons
(5%) reported adverse reactions to vaccine or to HRIG.
Discussion
Epidemiologic characteristics of possible rabies expo-
sure leading to PEP changed substantially in this 4-county
upstate New York area from 1993 to 2000. The major
changes were the animal species exposure source and type
of exposure (Table 4). From 1995 to 2000, overall PEP
incidence declined in this area to 27 cases/100,000 from a
high of 43 cases/100,000 in the early 1990s (9). Although
affected by complex factors, this may reflect increased
knowledge about what constitutes an exposure from terres-
trial mammals among the public and healthcare providers
and how to avoid exposures. 
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for a majority of the exposures from domestic animals (9).
Reinforced emphasis of responsible pet ownership and
routine vaccination with specific attention to the ideal of
maintaining cats indoors and up-to-date on their rabies
vaccinations may help to reverse this trend. At this time,
many states and localities do not require rabies vaccination
in cats. New York established a statewide requirement for
rabies vaccination for cats in 2002. Progress in this area
would be further enhanced through tangible enforcement
mechanisms.
The passive nature of PEP data collection is an inherent
weakness in most studies addressing PEP incidence. The
capture rate in this study is high because New York has a
requirement for reporting all PEP cases and provided par-
tial reimbursement to local health departments for uncov-
ered expenses. However, some cases may not have been
reported if costs were borne by the private sector.
Potential exposures to bats have replaced raccoons as
the most common species leading to PEP (Figure 3). By
1998, bats had become the leading source of exposure for
which PEP was sought in this area. Historically, bats have
only accounted for 5% to 10% of PEP cases (1,8,9).
Furthermore, most exposures to bats (62%) were cryptic or
listed as unknown; in other words, the exposure could not
be described as a bite from a bat or as direct or indirect
contamination of an open wound or mucous membrane
with infectious material from a bat.
One hypothesis in the debate surrounding cryptic bat
exposure and subsequent human rabies is that a bite from
a bat is dismissed as insignificant or is unrecognized by the
person because of somnolence or other impairment. For
example, 32 human rabies cases have been caused by bat
rabies virus variants from 1980 to 2004, but only 5 patients
reported a bite from a bat. However, a bat “encounter” was
recalled in 75% of cases, sometimes by family members or
associates. Moreover, bat bites do not typically require
medical attention for trauma from the bite itself (Figure 4).
Recognizing a potential exposure by the patient and
appropriate administration of PEP by healthcare profes-
sionals is critical to maintaining the low rates of human
rabies deaths observed in the United States. Although the
rate is low, the number of human rabies cases caused by
bat-associated rabies virus variants rose from 2 during the
1980s to 20 during the 1990s. This apparent increase in bat-
associated human rabies cases led to changes in the recom-
mendations for PEP to be considered in situations where a
bat is physically present, a bite cannot be ruled out, and
rabies cannot be ruled out by testing the bat. This caution-
ary language was formalized in the 1999 update of ACIP
recommendations for human rabies prevention and control
(7). Although these recommendations have been criticized
(11), they have been widely implemented in public health
practice. In addition to the ACIP recommendations, the
public health response in New York consisted of updated
rabies guidelines and an education campaign on bats and
rabies during the late 1990s (7,12,13). Though these guide-
lines may have increased PEP, informed decision-making
should always be used to reduce unnecessary PEP.
Despite increased educational emphasis on bats and
rabies, public knowledge about the risk of rabies exposure
from bats is lacking (13,14). ANew York study document-
ed that only 17%–26% of respondents knew that bats
found in homes should not be immediately released
(before considering the need to test the bat) (13).
Additionally, a Colorado study found that at least a third of
human encounters with bats that result in a possible expo-
sure could have been prevented by adopting a “do not
touch” approach to wildlife (15).
The deaths in 1993, 1994, and 1995 of 3 young girls in
New York, Washington, and Connecticut and the death of
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 12, December 2005 1925
Figure 3. Human rabies postexposure prophylaxis (PEP) associat-
ed with raccoon (A) or bat (B) exposures and the number of rac-
coons or bats that tested positive or negative for rabies, 4 upstate
New York counties (Cayuga, Monroe, Onondaga, and Wayne),
1993–2000.
Rabies Postexposure Prophylaxis, New Yorka New Jersey man in 1997 (16–19) caused by a bat rabies
virus variant elicited mass media attention. Sudden
increases in PEP after highly publicized rabies cases or
exposures have been previously described (20,21). Local
and national events that involve a potential rabies case may
affect how persons and physicians assess the risk of an ani-
mal exposure, perhaps leading to use of PEPin an environ-
ment of heightened concern rather than in response to a
true exposure (21,22). 
The 1999 ACIP guidelines (currently in the nascent
stages of another update), as well as the availability of
expert consultation at the local, state, and national level,
should be widely promoted among healthcare profession-
als responsible for advising patients and providing PEP.
Ultimately, public education about bats and rabies may
increase the number of persons who seek PEP. A balanced
approach is necessary to curtail inappropriate PEP and
avoid unnecessary human deaths, such as the recent
California case in which a patient did not seek PEP after a
bat bite (23). Similarly, the recent Wisconsin human rabies
case resulting from a bat bite was preventable had the risk
been understood and had PEP been sought and appropri-
ately administered. Survivorship in this case provides a
welcome but extremely rare exception to the paradigm of
rabies as inevitably lethal (24). It does not alter the ulti-
mate goal of absolute human rabies prevention.
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Einstein didn’t speak as a child
waiting till a sentence formed and
emerged full-blown from his head.
I do the thing, he later wrote, which
nature drives me to do. Does a fish
know the water in which he swims?
This came up in conversation
with a man I met by chance,
friend of a friend of a friend,
who passed through town carrying
three specimen boxes of insects
he’d collected in the Grand Canyon—
one for mosquitoes, one for honeybees,
one for butterflies and skippers,
each lined up in a row, pinned and labeled,
tiny morphologic differences
revealing how adaptation
happened over time. The deeper down
he hiked, the older the rock
and the younger
the strategy for living in that place.
And in my dining room the universe
found its way into this man
bent on cataloguing each innovation,
though he knows it will all disappear—
the labels, the skippers, the canyon.
We agreed then, the old friends and the new,
that it’s wrong to think people are a thing apart
from the whole, as if we’d sprung
from an idea out in space, rather than emerging
from the sequenced larval mess of creation
that binds us with the others,
all playing the endgame of a beautiful planet
that’s made us want to name
each thing and try to tell 
its story against the vanishing.
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